JPM

305.35

+0.44%↑

BAC

52.82

-0.28%↓

WFC

86.83

-0.14%↓

MS

165.1

-0.46%↓

AXP

361.54

+0.04%↑

JPM

305.35

+0.44%↑

BAC

52.82

-0.28%↓

WFC

86.83

-0.14%↓

MS

165.1

-0.46%↓

AXP

361.54

+0.04%↑

JPM

305.35

+0.44%↑

BAC

52.82

-0.28%↓

WFC

86.83

-0.14%↓

MS

165.1

-0.46%↓

AXP

361.54

+0.04%↑

JPM

305.35

+0.44%↑

BAC

52.82

-0.28%↓

WFC

86.83

-0.14%↓

MS

165.1

-0.46%↓

AXP

361.54

+0.04%↑

JPM

305.35

+0.44%↑

BAC

52.82

-0.28%↓

WFC

86.83

-0.14%↓

MS

165.1

-0.46%↓

AXP

361.54

+0.04%↑

Search

Walker & Dunlop Inc

Cerrado

SectorFinanzas

82.98 -2.57

Resumen

Variación precio

24h

Actual

Mínimo

82.35

Máximo

85.31

Métricas clave

By Trading Economics

Ingresos

30M

33M

Ventas

59M

296M

P/B

Media del Sector

26.346

27.54

Rentabilidad por dividendo

3.08

Margen de beneficios

11.191

Empleados

1,399

EBITDA

43M

122M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+12.46% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

3.08%

3.88%

Próximas Ganancias

6 nov 2025

Fecha Próximo Dividendo

5 dic 2025

Próxima Fecha de Ex Dividendo

21 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

337M

2.9B

Apertura anterior

85.55

Cierre anterior

82.98

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

190 / 529 Clasificación en Finance

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

Walker & Dunlop Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

28 oct 2025, 23:50 UTC

Acciones populares

Stocks to Watch: Caesars, Enphase, Mondelez, Teradyne

28 oct 2025, 23:25 UTC

Ganancias

SK Hynix Posts Record Earnings on Continued AI-Chip Demand

28 oct 2025, 23:18 UTC

Ganancias

Booking 3Q Sales Rise as U.S. Travel Demand Stabilizes -- Update

28 oct 2025, 22:20 UTC

Ganancias

Visa Sales Jump as Consumers Keep Spending -- 2nd Update

28 oct 2025, 22:13 UTC

Ganancias

Wal-Mart de Mexico Net Profit Falls in 3Q

28 oct 2025, 21:38 UTC

Ganancias

Correction to Visa Sales Jump Article

28 oct 2025, 21:17 UTC

Ganancias

OrthoPediatrics Wins FDA Approval for Surgery Plating System; 3Q Revenue Rises

28 oct 2025, 21:07 UTC

Ganancias

Visa Sales Jump as Consumers Keep Spending -- Update

28 oct 2025, 21:02 UTC

Ganancias

Mondelez Tempers Outlook as Costs Rise

28 oct 2025, 23:51 UTC

Charlas de Mercado

Nikkei May Rise on Easing U.S.-China Tensions -- Market Talk

28 oct 2025, 23:42 UTC

Charlas de Mercado

Gold Edges Lower on Possible Position Adjustments Ahead of FOMC Decision -- Market Talk

28 oct 2025, 23:02 UTC

Ganancias

SK Hynix: HBM4 Shipments to Start in 4Q, Ahead of Full-Scale Sales Expansion in 2026

28 oct 2025, 23:01 UTC

Ganancias

SK Hynix: Completed Discussions With Key Customers About 2026 HMB Supply

28 oct 2025, 22:46 UTC

Ganancias

SK Hynix: Co. Secured Full Customer Demand for Its Entire DRAM and NAND Production for Next Yr >000660.SE

28 oct 2025, 22:45 UTC

Ganancias

SK Hynix 3Q Net KRW12.6T >000660.SE

28 oct 2025, 22:44 UTC

Ganancias

SK Hynix 3Q Rev KRW24.44T >000660.SE

28 oct 2025, 22:43 UTC

Ganancias

SK Hynix 3Q Net Profit Beat FactSet-Compiled Consensus

28 oct 2025, 22:42 UTC

Ganancias

SK Hynix 3Q Net KRW12.598T Vs. Net KRW5.753T >000660.SE

28 oct 2025, 22:40 UTC

Ganancias

SK Hynix 3Q Rev KRW24.449T Vs. KRW17.573T >000660.SE

28 oct 2025, 22:40 UTC

Ganancias

SK Hynix 3Q Oper Pft KRW11.383T Vs. Pft KRW7.030T >000660.SE

28 oct 2025, 22:22 UTC

Ganancias

Pharmaron Beijing: Higher Contributions From Clinical-Development Services Supported Results >300759.SZ

28 oct 2025, 22:22 UTC

Ganancias

Pharmaron Beijing: Higher Contributions From Laboratory Services Supported Results >300759.SZ

28 oct 2025, 22:22 UTC

Ganancias

Pharmaron Beijing 3Q Net CNY439.52M, Up 42.5% on Year >300759.SZ

28 oct 2025, 22:20 UTC

Ganancias

Pharmaron Beijing 3Q Rev CNY3.64B, Up 13.4% on Year >300759.SZ

28 oct 2025, 22:02 UTC

Ganancias

Review & Preview: Earnings Extravaganza -- Barrons.com

28 oct 2025, 21:42 UTC

Charlas de Mercado
Ganancias

Global Equities Roundup: Market Talk

28 oct 2025, 21:42 UTC

Charlas de Mercado
Ganancias

Mondelez Says Cocoa Costs Peaked Heading Into Spooky Season -- Market Talk

28 oct 2025, 21:20 UTC

Ganancias

Wal-Mart de Mexico 3Q EBITDA MXN25.27B, Up 3.3% on Year

28 oct 2025, 21:19 UTC

Ganancias

Wal-Mart de Mexico 3Q Rev MXN241.52B, Up 4.9% on Year

28 oct 2025, 21:18 UTC

Ganancias

Wal-Mart de Mexico 3Q Net MXN11.75B, Down 9.2% on Year

Comparación entre iguales

Cambio de precio

Walker & Dunlop Inc previsión

Precio Objetivo

By TipRanks

12.46% repunte

Estimación a 12 Meses

Media 96 USD  12.46%

Máximo 97 USD

Mínimo 95 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Walker & Dunlop Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

2

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

70.995 / 76.69Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

No Evidence

Sentimiento

By Acuity

190 / 529 Clasificación en Finanzas

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Walker & Dunlop Inc

Walker & Dunlop, Inc. is a holding company, which conducts its operations through Walker & Dunlop, LLC. The Company provides commercial real estate and financial services. It originates, sells, and services a range of commercial real estate debt and equity financing products and provides multifamily property sales brokerage and valuation services. It is also engaged in commercial real estate investment management activities. The Company provides housing market research and delivers real estate-related investment banking and advisory services. Through its agency products, the Company originates and sells loans pursuant to the programs of the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Federal Housing Administration. Through its debt brokerage products, the Company brokers, and in some cases services, loans for various life insurance companies, commercial banks, commercial mortgage-backed securities issuers and other institutional investors.
help-icon Live chat